171 related articles for article (PubMed ID: 537884)
21. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa with phage F 116 and AP 19, a new wildtype phage.
Knothe H; Lebek G; Krcméry V; Seginková Z; Cervenka J; Antal M; Mitsuhashi S
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):506-10. PubMed ID: 6800151
[TBL] [Abstract][Full Text] [Related]
22. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
Juhlin I; Tunevall G
Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
[TBL] [Abstract][Full Text] [Related]
23. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
Ximenes J; Hirai CK; Takenaka IM
J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
[TBL] [Abstract][Full Text] [Related]
24. [In vitro study of the synergistic effect of cefotiam- aminoglycoside combinations on strains of low susceptibility to this cephalosporin].
Husson MO; Izard D; Leclerc H
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):466-8. PubMed ID: 3911141
[TBL] [Abstract][Full Text] [Related]
25. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
Eickhoff TC; Ehret JM
Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
[TBL] [Abstract][Full Text] [Related]
27. [Comparative study of the sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa with 4 aminoglycosides].
Turgeon P; Lamothe F; Vincelette J; Gaudreau C; Bourgault AM; Turgeon F
Union Med Can; 1984 Jun; 113(6):522-4. PubMed ID: 6435299
[No Abstract] [Full Text] [Related]
28. Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.
Seligman SJ
Antimicrob Agents Chemother; 1978 Jan; 13(1):70-3. PubMed ID: 626492
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
Braveny I; Voeckl J; Machka K
Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
[TBL] [Abstract][Full Text] [Related]
30. Gentamicin-resistant gram-negative bacilli in hospital patients. Part II. In vitro aspects including susceptibility to tobramycin and amikacin.
Block CS; Fabian B; Robinson RG
S Afr Med J; 1978 Mar; 53(11):396-99. PubMed ID: 675374
[TBL] [Abstract][Full Text] [Related]
31. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
Ronco E; Migueres ML; Vacheron F; Guenounou M
Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
[TBL] [Abstract][Full Text] [Related]
32. [New plasmid resistance of Staphylococcus aureus to aminosides (gentamicin, tobramycin, amikacin].
Soussy CJ; Dublanchet A; Cormier M; Bismuth R; Mizon F; Chardon H; Duval J; Fabiani G
Nouv Presse Med; 1976 Nov; 5(39):2599-602. PubMed ID: 995590
[TBL] [Abstract][Full Text] [Related]
33. Letter: Activities of tobramycin and amikacin against gentamicin-resistant gram-negative bacilli.
Houang ET; McKay-Ferguson E
Lancet; 1976 Feb; 1(7956):423-4. PubMed ID: 55682
[No Abstract] [Full Text] [Related]
34. [Phenotypes of resistance to aminosides and sensitivity of amikacin in hospitals].
Witchitz JL; Golstein FW; Pangon B; Christol D; Acar JF
Nouv Presse Med; 1979 Oct; 8(42):3417-20. PubMed ID: 537886
[No Abstract] [Full Text] [Related]
35. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
[TBL] [Abstract][Full Text] [Related]
36. Combination effect of cefmenoxime with four aminoglycosides on Enterobacteriaceae susceptible and moderately susceptible to this new cephalosporin.
Husson MO; Izard D; Bryskier A; Vincent P; Leclerc H
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):383-7. PubMed ID: 6091368
[TBL] [Abstract][Full Text] [Related]
37. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
Christe M; Vaudaux P; Waldvogel FA
Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
[TBL] [Abstract][Full Text] [Related]
38. [Pseudomonas: microbiological aspects and sensitivity to tobramycin and gentamycin].
Ceruti T; Bassi L; Biazzi E; Fasani AM; Pedroni P
Arch Sci Med (Torino); 1982; 139(4):463-5. PubMed ID: 6820271
[TBL] [Abstract][Full Text] [Related]
39. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
[TBL] [Abstract][Full Text] [Related]
40. Gentamicin-resistant Serratia marcescens endophthalmitis.
Gammon JA; Schwab I; Joseph P
Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
